Kabra Drugs Ltd PE Ratio

Kabra Drugs PE Ratio

Image

Kabra Drugs Ltd

NSE: KABRADRUGS

PE

6.3

Last updated on: Sep 07, 2026

Key Highlights

  • The P/E Ratio of Kabra Drugs Ltd is 6.3 as of 07 Sep 26 The P/E Ratio of Kabra Drugs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years .

Historical P/E Ratio of Kabra Drugs Ltd

No data available

Company Fundamentals for Kabra Drugs Ltd

Image

Kabra Drugs Ltd

NSE: KABRADRUGS

Share Price

₹ -

Last updated on: Jan 01, 2026

Market Price of Kabra Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Kabra Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Sep 202620.18
04 Sep 202619.98
03 Sep 202619.34
02 Sep 202619.8
01 Sep 202619.65
31 Aug 202619.82
28 Aug 202619.97
27 Aug 202620.49
26 Aug 202620.93
25 Aug 202621.2

BlinkX Score for Kabra Drugs Ltd

Asset Value vs Market Value of Kabra Drugs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Key Valuation Metric of Kabra Drugs Ltd

X

Historical Market Cap of Kabra Drugs Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Kabra Drugs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Kabra Drugs Ltd

No data available

* All values are in %

About Kabra Drugs Ltd

  • Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989.
  • The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical.
  • The commercial production commenced in 1991.
  • Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.
  • The Company has 500+ products across India. The Company was incorporated with a mission to enrich the lives through pharmaceutical solutions which are innovative, high-quality and accessible to every family it serves.

Kabra Drugs Ltd News Hub

Kabra Drugs reports standalone net loss of Rs 0.55 crore in the June 2024 quarter

Net Loss of Kabra Drugs reported to Rs 0.55 crore in the quarter ended June 2024 as against net loss

Read more

16 Aug 24

Kabra Drugs announces board meeting date

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2024. Powered

Read more

09 Aug 24

Kabra Drugs to consider Fund Raising

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 November 2024. Powered

Read more

22 Oct 24

Kabra Drugs to conduct board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 2 September 2024. Powere

Read more

28 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions